Oppenheimer analyst Francois Brisebois upgraded Ovid Therapeutics Inc (NASDAQ:OVID) from Perform to Outperform, establishing a price target of $4.00. The upgrade comes as the stock trades near its ...

Imagine North Dakota being forced to cut back on pumping crude oil -- not because of a lack of oil, but because it has too ...

Ascendis Pharma boasts several commercial stage products. Read why ASND stock is an interesting speculative investment ...

MLB Pipeline's new Top 100 Prospects list was released late last week, crowning Dodgers right-hander Roki Sasaki as MLB's No.

The Memphis-based organization has established the Innovate Xcelerate initiative, which is intended to expand Memphis' ...

China’s thermal power generation reached a record high in 2024, primarily due to the country’s coal-fired power plants, even ...

In Brief Many accounting leaders and observers have pointed out the need to expand the pipeline to the profession and ...

The looming talent shortage in financial services presents a serious challenge but also offers an opportunity to rethink how ...

Dr. Oz says rubbing coffee grounds on your naked body will get rid of cellulite. Apparently, you can't do this in the ...

The Mid-Penn Conference to PSAC pipeline continues to grow as Chambersburg linebacker Stanley Lozius becomes the latest MPC ...

When a government bureaucracy wants to do something that’s of dubious popularity, they call it a “pilot project.” The odds ...

Vertex's lineup will look transformed in five years, and the company should continue performing well beyond that time. It's ...